Equities

Oncosil Medical Ltd

Oncosil Medical Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.008
  • Today's Change-0.001 / -11.11%
  • Shares traded7.45m
  • 1 Year change-5.88%
  • Beta1.5620
Data delayed at least 20 minutes, as of Oct 31 2024 05:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade, Oncosil Medical Ltd (OSL:ASX) traded at 0.008, 100.00% above the 52 week low of 0.004 set on Jun 28, 2024.
52-week range
Today
0.004Jun 28 20240.015Oct 16 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.008
High0.0085
Low0.008
Bid0.012
Offer0.008
Previous close0.009
Average volume10.77m
Shares outstanding3.78bn
Free float3.65bn
P/E (TTM)--
Market cap34.06m AUD
EPS (TTM)-0.0054
AUD
Data delayed at least 20 minutes, as of Oct 31 2024 05:10 BST.
More ▼

Events & Activity

  • OSL:ASX trading volume exceeds daily average by +234.79%
  • OSL:ASX price falls below 200-day moving average to 0.008 at 19:06 BST
  • OSL:ASX price moved over -23.08% to 0.01
  • OSL:ASX price falls below 50-day moving average to 0.01 at 19:06 BST
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.